$IMMU Recent Headlines Alcoa shares slip as ea
Post# of 72741
Posted On: 01/05/2015 9:25:40 AM
$IMMU Recent Headlines
Alcoa shares slip as earnings miss Street view 5:57 p.m. Jan. 9, 2014 - Wallace Witkowski
S&P back for another crack at the 50-day average 10:30 a.m. Oct. 3, 2013 - Michael Ashbaugh
Stocks to watch Thursday: Hain, Guess, H-P 6:00 a.m. Aug. 23, 2012 - MarketWatch
Immunomedics, UCB tweak pact on cancer, lupus drug 1:53 a.m. Dec. 28, 2011 - Robert Daniel
Wednesday’s biggest gaining and declining stocks 3:29 p.m. Aug. 24, 2011 - Kate Gibson
Pernix leads drug stocks south 12:31 p.m. May 17, 2011 - Val Brickates Kennedy
Immunomedics jumps; indices slip 10:11 a.m. May 13, 2010 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:37 p.m. Jan. 19, 2010 - MarketWatch
Enthusiasm for lupus drug fuels HGS shares 6:00 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:46 p.m. Aug. 28, 2009 - MarketWatch
Stocks in focus for Friday 6:18 p.m. Aug. 27, 2009 - MarketWatch
Thursday's biggest gaining and declining stocks 3:36 p.m. Aug. 27, 2009 - MarketWatch
Drug stocks mixed; Immunomedics soars 11:47 a.m. Aug. 27, 2009 - Val Brickates Kennedy
Immunomedics shares up 62% 8:34 a.m. Aug. 27, 2009 - Nick Godt
Immunomedics rallies on lupus drug study 6:28 a.m. Aug. 27, 2009 - Steve Goldstein
Financials a major drag on U.S. benchmarks 9:36 a.m. Nov. 5, 2007 - Michael Ashbaugh
Another spectacular whipsaw for the U.S. markets 8:34 a.m. Oct. 25, 2007 - Michael Ashbaugh
Dow edges atop the 50-day moving average 8:24 a.m. March 26, 2007 - Michael Ashbaugh
U.S. markets try to extend this week's rally 10:12 a.m. March 8, 2007 - Michael Ashbaugh
Nasdaq manages another successful test of the 50-day 9:44 a.m. Feb. 14, 2007 - Michael Ashbaugh
Immunomedics: Under-Followed Company With Robust Pipeline And Huge Growth Potential 5:17 p.m. Dec. 26, 2014 - Seeking Alpha
Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog 4:20 p.m. Nov. 24, 2014 - Zacks.com
Immunomedics' (IMMU) CEO Cynthia Sullivan on Q1 2015 Results - Earnings Call Transcript 2:36 p.m. Nov. 10, 2014 - Seeking Alpha
Immunomedics (IMMU) Weak On High Volume 10:02 a.m. Nov. 6, 2014 - TheStreet.com
10-Q: IMMUNOMEDICS INC 4:40 p.m. Nov. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
BI begins enrollment in Phase 3 CRC trial 8:08 a.m. Oct. 21, 2014 - Seeking Alpha
Immunomedics (IMMU) Jumps: Stock Adds 9.1% is Session - Tale of the Tape 8:39 a.m. Sept. 30, 2014 - Zacks.com
Is Immunomedics (IMMU) Stock a Solid Choice Right Now? - Tale of the Tape 7:37 a.m. Sept. 30, 2014 - Zacks.com
Immunomedics (IMMU) Flagged As Strong On High Volume 9:03 a.m. Sept. 29, 2014 - TheStreet.com
Can Immunomedics (IMMU) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 7:53 a.m. Sept. 29, 2014 - Zacks.com
8 Analyst Stocks Under $10 With Massive Upside Calls 7:35 a.m. Sept. 27, 2014 - 247WallSt.com
Immunomedics Inc. (IMMU) Jumps: Stock Up 6.6% in Session - Tale of the Tape 8:39 a.m. Sept. 25, 2014 - Zacks.com
Immunomedics' (IMMU) CEO Cynthia Sullivan on Q4 2014 Results - Earnings Call Transcript 3:58 p.m. Aug. 26, 2014 - Seeking Alpha
10-K: IMMUNOMEDICS INC 3:58 p.m. Aug. 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
Immunomedics' IMMU-132 Gets Orphan Drug Status - Analyst Blog 5:10 p.m. June 10, 2014 - Zacks.com
Cramer's Mad Money - The Cure For Yahoo Ennui (5/22/14) 4:39 a.m. May 23, 2014 - Seeking Alpha
Immunomedics' (IMMU) CEO Cynthia Sullivan on F3Q 2014 Results - Earnings Call Transcript 4:32 a.m. May 11, 2014 - Seeking Alpha
10-Q/A: IMMUNOMEDICS INC 5:06 a.m. March 19, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: IMMUNOMEDICS INC 5:05 a.m. March 19, 2014 - Edgar Online - (EDG = 10Q, 10K)
Immunomedics' CEO Discusses F2Q 2014 Results - Earnings Call Transcript 1:58 p.m. Feb. 11, 2014 - Seeking Alpha
Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan (IMMU-132) for Triple-Negative Breast Cancer Therapy 54 min ago - GlobeNewswire
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris 8:40 a.m. Dec. 17, 2014 - PR Newswire - PRF
Immunomedics Reports Preliminary Results From Pretargeted Imaging Study in Patients With Metastatic Breast Cancer 8:31 a.m. Dec. 15, 2014 - GlobeNewswire
Immunomedics Reports Expanded Phase 1/2 Trials Confirm Activity and Good Safety Profile of Sacituzumab Govitecan (Immu-132) in Patients With Advanced Triple-Negative Breast Cancer 8:31 a.m. Dec. 12, 2014 - GlobeNewswire
Immunomedics to Present at 25th Annual Oppenheimer Healthcare Conference 8:30 a.m. Dec. 4, 2014 - GlobeNewswire
Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders 1:00 p.m. Dec. 3, 2014 - GlobeNewswire
Immunomedics Presents Clinical Data on Novel Antibody-Drug Conjugates for Solid Cancer Therapy 8:31 a.m. Nov. 20, 2014 - GlobeNewswire
Immunomedics Announces Six Presentations on Epratuzumab in Lupus at Leading Rheumatology Meeting 8:31 a.m. Nov. 14, 2014 - GlobeNewswire
Immunomedics Receives Third Edison Patent Award From Research & Development Council of New Jersey 8:31 a.m. Nov. 7, 2014 - GlobeNewswire
Immunomedics Announces First Quarter Fiscal 2015 Results and Clinical Program Developments 4:01 p.m. Nov. 5, 2014 - GlobeNewswire
Immunomedics Provides Update on Phase 2 Study of Isactuzumab Govitecan in Patients With Diverse Metastatic Solid Cancers 2:01 p.m. Oct. 29, 2014 - GlobeNewswire
Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2015 Financial Results 7:31 a.m. Oct. 27, 2014 - GlobeNewswire
Immunomedics to Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates at Upcoming Conferences 7:31 a.m. Oct. 22, 2014 - GlobeNewswire
Immunomedics Announces European Orphan Drug Designation for Isactuzumab Govitecan for Pancreatic Cancer Treatment 7:31 a.m. Oct. 20, 2014 - GlobeNewswire
Immunomedics Announces Presentations at the 2014 European Association of Nuclear Medicine Congress 7:31 a.m. Oct. 13, 2014 - GlobeNewswire
Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 7:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Immunomedics Publishes Results on Immunotherapy of Solid Cancers Mediated by a Novel Bispecific Antibody 7:31 a.m. Sept. 26, 2014 - GlobeNewswire
Immunomedics Announces Fiscal 2014 Results and Clinical Program Developments 3:01 p.m. Aug. 25, 2014 - GlobeNewswire
Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2014 Financial Results 7:34 a.m. Aug. 11, 2014 - GlobeNewswire
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Alcoa shares slip as earnings miss Street view 5:57 p.m. Jan. 9, 2014 - Wallace Witkowski
S&P back for another crack at the 50-day average 10:30 a.m. Oct. 3, 2013 - Michael Ashbaugh
Stocks to watch Thursday: Hain, Guess, H-P 6:00 a.m. Aug. 23, 2012 - MarketWatch
Immunomedics, UCB tweak pact on cancer, lupus drug 1:53 a.m. Dec. 28, 2011 - Robert Daniel
Wednesday’s biggest gaining and declining stocks 3:29 p.m. Aug. 24, 2011 - Kate Gibson
Pernix leads drug stocks south 12:31 p.m. May 17, 2011 - Val Brickates Kennedy
Immunomedics jumps; indices slip 10:11 a.m. May 13, 2010 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:37 p.m. Jan. 19, 2010 - MarketWatch
Enthusiasm for lupus drug fuels HGS shares 6:00 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:46 p.m. Aug. 28, 2009 - MarketWatch
Stocks in focus for Friday 6:18 p.m. Aug. 27, 2009 - MarketWatch
Thursday's biggest gaining and declining stocks 3:36 p.m. Aug. 27, 2009 - MarketWatch
Drug stocks mixed; Immunomedics soars 11:47 a.m. Aug. 27, 2009 - Val Brickates Kennedy
Immunomedics shares up 62% 8:34 a.m. Aug. 27, 2009 - Nick Godt
Immunomedics rallies on lupus drug study 6:28 a.m. Aug. 27, 2009 - Steve Goldstein
Financials a major drag on U.S. benchmarks 9:36 a.m. Nov. 5, 2007 - Michael Ashbaugh
Another spectacular whipsaw for the U.S. markets 8:34 a.m. Oct. 25, 2007 - Michael Ashbaugh
Dow edges atop the 50-day moving average 8:24 a.m. March 26, 2007 - Michael Ashbaugh
U.S. markets try to extend this week's rally 10:12 a.m. March 8, 2007 - Michael Ashbaugh
Nasdaq manages another successful test of the 50-day 9:44 a.m. Feb. 14, 2007 - Michael Ashbaugh
Immunomedics: Under-Followed Company With Robust Pipeline And Huge Growth Potential 5:17 p.m. Dec. 26, 2014 - Seeking Alpha
Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog 4:20 p.m. Nov. 24, 2014 - Zacks.com
Immunomedics' (IMMU) CEO Cynthia Sullivan on Q1 2015 Results - Earnings Call Transcript 2:36 p.m. Nov. 10, 2014 - Seeking Alpha
Immunomedics (IMMU) Weak On High Volume 10:02 a.m. Nov. 6, 2014 - TheStreet.com
10-Q: IMMUNOMEDICS INC 4:40 p.m. Nov. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
BI begins enrollment in Phase 3 CRC trial 8:08 a.m. Oct. 21, 2014 - Seeking Alpha
Immunomedics (IMMU) Jumps: Stock Adds 9.1% is Session - Tale of the Tape 8:39 a.m. Sept. 30, 2014 - Zacks.com
Is Immunomedics (IMMU) Stock a Solid Choice Right Now? - Tale of the Tape 7:37 a.m. Sept. 30, 2014 - Zacks.com
Immunomedics (IMMU) Flagged As Strong On High Volume 9:03 a.m. Sept. 29, 2014 - TheStreet.com
Can Immunomedics (IMMU) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 7:53 a.m. Sept. 29, 2014 - Zacks.com
8 Analyst Stocks Under $10 With Massive Upside Calls 7:35 a.m. Sept. 27, 2014 - 247WallSt.com
Immunomedics Inc. (IMMU) Jumps: Stock Up 6.6% in Session - Tale of the Tape 8:39 a.m. Sept. 25, 2014 - Zacks.com
Immunomedics' (IMMU) CEO Cynthia Sullivan on Q4 2014 Results - Earnings Call Transcript 3:58 p.m. Aug. 26, 2014 - Seeking Alpha
10-K: IMMUNOMEDICS INC 3:58 p.m. Aug. 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
Immunomedics' IMMU-132 Gets Orphan Drug Status - Analyst Blog 5:10 p.m. June 10, 2014 - Zacks.com
Cramer's Mad Money - The Cure For Yahoo Ennui (5/22/14) 4:39 a.m. May 23, 2014 - Seeking Alpha
Immunomedics' (IMMU) CEO Cynthia Sullivan on F3Q 2014 Results - Earnings Call Transcript 4:32 a.m. May 11, 2014 - Seeking Alpha
10-Q/A: IMMUNOMEDICS INC 5:06 a.m. March 19, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: IMMUNOMEDICS INC 5:05 a.m. March 19, 2014 - Edgar Online - (EDG = 10Q, 10K)
Immunomedics' CEO Discusses F2Q 2014 Results - Earnings Call Transcript 1:58 p.m. Feb. 11, 2014 - Seeking Alpha
Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan (IMMU-132) for Triple-Negative Breast Cancer Therapy 54 min ago - GlobeNewswire
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris 8:40 a.m. Dec. 17, 2014 - PR Newswire - PRF
Immunomedics Reports Preliminary Results From Pretargeted Imaging Study in Patients With Metastatic Breast Cancer 8:31 a.m. Dec. 15, 2014 - GlobeNewswire
Immunomedics Reports Expanded Phase 1/2 Trials Confirm Activity and Good Safety Profile of Sacituzumab Govitecan (Immu-132) in Patients With Advanced Triple-Negative Breast Cancer 8:31 a.m. Dec. 12, 2014 - GlobeNewswire
Immunomedics to Present at 25th Annual Oppenheimer Healthcare Conference 8:30 a.m. Dec. 4, 2014 - GlobeNewswire
Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders 1:00 p.m. Dec. 3, 2014 - GlobeNewswire
Immunomedics Presents Clinical Data on Novel Antibody-Drug Conjugates for Solid Cancer Therapy 8:31 a.m. Nov. 20, 2014 - GlobeNewswire
Immunomedics Announces Six Presentations on Epratuzumab in Lupus at Leading Rheumatology Meeting 8:31 a.m. Nov. 14, 2014 - GlobeNewswire
Immunomedics Receives Third Edison Patent Award From Research & Development Council of New Jersey 8:31 a.m. Nov. 7, 2014 - GlobeNewswire
Immunomedics Announces First Quarter Fiscal 2015 Results and Clinical Program Developments 4:01 p.m. Nov. 5, 2014 - GlobeNewswire
Immunomedics Provides Update on Phase 2 Study of Isactuzumab Govitecan in Patients With Diverse Metastatic Solid Cancers 2:01 p.m. Oct. 29, 2014 - GlobeNewswire
Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2015 Financial Results 7:31 a.m. Oct. 27, 2014 - GlobeNewswire
Immunomedics to Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates at Upcoming Conferences 7:31 a.m. Oct. 22, 2014 - GlobeNewswire
Immunomedics Announces European Orphan Drug Designation for Isactuzumab Govitecan for Pancreatic Cancer Treatment 7:31 a.m. Oct. 20, 2014 - GlobeNewswire
Immunomedics Announces Presentations at the 2014 European Association of Nuclear Medicine Congress 7:31 a.m. Oct. 13, 2014 - GlobeNewswire
Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 7:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Immunomedics Publishes Results on Immunotherapy of Solid Cancers Mediated by a Novel Bispecific Antibody 7:31 a.m. Sept. 26, 2014 - GlobeNewswire
Immunomedics Announces Fiscal 2014 Results and Clinical Program Developments 3:01 p.m. Aug. 25, 2014 - GlobeNewswire
Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2014 Financial Results 7:34 a.m. Aug. 11, 2014 - GlobeNewswire
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
(0)
(0)